BBNX - betabionics.com Market Value

Beta Bionics Inc (BBNX) develops autonomous diabetes control systems utilizing FDA-cleared precision hormone delivery algorithms. The brand is highly regarded by physicians for developing a "bionic pancreas" that simplifies patients' daily lives. The stock price history reflects a market capitalization of 0.89. Beta Bionics Inc (BBNX) adheres to environmental standards through packaging optimization and electronics control, as illustrated in this chart.

BBNX (Beta Bionics) Market Capitalization history from 01/31/2025 to 11/13/2026

Financial and market metric breakdowns for iLet Bionic Pancreas (BBNX)

- current price and projected stock value:

Stock Price Beta Bionics|BBNX - Price Target Chart

- market capitalization statistics:

Market Value iLet Bionic Pancreas|BBNX - Business Value

- book value of equity indicators:

Accounting Value per Share Beta Bionics|BBNX - Accounting Capitalization|Market Value to Book Value Ratio betabionics.com|BBNX - Company Total Asset Base

- company total debt and liquidity indicators:

- net income and valuation multiples indicators:

BBNX - Net Profit|Expected Profit Beta Bionics Inc|BBNX - Price to Earnings Ratio|Forward P/E Multiple Beta Bionics Corp|BBNX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio iLet Bionic Pancreas|BBNX - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Beta Bionics|BBNX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth betabionics.com|BBNX - Earnings per share growth this year|Expected earnings per share growth for next year Beta Bionics Inc

- sales and revenue indicators:

BBNX - Company Sales Revenue|Company Projected Revenue Beta Bionics|BBNX - Market Cap to Revenue|Forward P/S Multiple iLet Bionic Pancreas

Initial company analysis:Beta Bionics BBNX

Original product of iLet Bionic Pancreas

When selecting assets with a high margin of safety, analyzing market capitalization is key, as it aggregates the value of all shares to determine the balance of supply and demand. This metric reflects the investment potential of Beta Bionics Inc (BBNX): the issuer's current total market value indicates how the market prices in the synergy of integrating the iLet system into endocrinology practice.

Competitors of Beta Bionics Inc (BBNX)